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An attempt has been made to improve a crystal contact of human acidic
ﬁbroblast growth factor (haFGF; 140 amino acids) to control the crystal growth,
because haFGF crystallizes only as a thin-plate form, yielding crystals suitable
for X-ray but not neutron diffraction. X-ray crystal analysis of haFGF showed
that the Glu81 side chain, located at a crystal contact between haFGF molecules,
is in close proximity with an identical residue related by crystallographic
symmetry, suggesting that charge repulsion may disrupt suitable crystal-packing
interactions. To investigate whether the Glu residue affects the crystal-packing
interactions, haFGF mutants in which Glu81 was replaced by Ala, Val, Leu, Ser
and Thr were constructed. Although crystals of the Ala and Leu mutants were
grown as a thin-plate form by the same precipitant (formate) as the wild type,
crystals of the Ser and Thr mutants were grown with increased thickness,
yielding a larger overall crystal volume. X-ray structural analysis of the Ser
mutant determined at 1.35 A ˚ resolution revealed that the hydroxy groups of Ser
are linked by hydrogen bonds mediated by the formate used as a precipitant.
This approach to engineering crystal contacts may contribute to the
development of large protein crystals for neutron crystallography.
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1. Introduction
Protein crystallization constitutes a key limiting step in structural
characterization by diffraction methods. Proteins of interest are
screened against a multitude of prepared solutions because rational
prediction of protein crystallization conditions has been impossible,
despite knowledge of the physics and thermodynamics of protein
crystallization. Development of high-throughput crystallization
devices, able to set up over 100000 samples per day, accelerates
screening of protein crystallization conditions (Stevens, 2000). It is,
however, reported that the success rates of crystallization of proteins
that are expressed as a soluble form in Escherichia coli are less than
30% (Dale et al., 2003).
Proteins in a crystal lattice align with each other through weak
interactions on the surface of the protein. Controlling this weak
interaction by protein engineering is very important to produce
successful crystal packing or control the crystal growth. Recent
studies show that targeted mutagenesis of surface patches containing
residues with large ﬂexible side chains (i.e. Lys and Glu) and their
replacement with smaller amino acids (typically Ala) (Derewenda &
Vekilov, 2006), derivatization by methylation (Walter et al., 2006) or
complexation with antibodies (Ostermeier et al., 1995; Kuroki et al.,
2002; Feese et al., 2004) can lead to effective preparation of X-ray
quality crystals of proteins. Moreover, creation of symmetric crystal
contacts by mutagenesis has also been attempted by introduction of a
disulﬁde bond (Heinz & Matthews, 1994; Banatao et al., 2006) and
leucine zipper (Yamada et al., 2007). Therefore, it is considered that
engineering of the crystal contact is an important approach to
increase the volume of protein crystals, particularly for neutron
diffraction studies.
Human acidic ﬁbroblast growth factor (haFGF) is a member of a
family of heparin-binding mitogens and hormones (Johnson et al.,
1991; Jaye et al., 1992), and the X-ray structure has already been
determined to 1.10 A ˚ resolution (Bernett et al., 2004). However,
haFGF crystallizes as a thin-plate form with corresponding limita-
tions for neutron diffraction studies. By X-ray crystal structure
analysis, it is hypothesized that the proximity of the side chains of
Glu81, located at a crystal contact between haFGF molecules related
by crystallographic symmetry, may disrupt suitable crystal-packing
interactions (along the b axis) by charge repulsion and/or entropy
effects. To investigate whether the Glu residue affects crystal-packing
interactions, we constructed haFGF mutants in which Glu81 was
replaced by Ala, Val, Leu, Ser and Thr.
2. Materials and methods
2.1. Expression and purification
A synthetic polynucleotide coding the 140-amino-acid form of
human FGF-1 (Gimenez-Gallego et al., 1986; Linemeyer et al., 1990;
Ortega et al., 1991; Blaber et al., 1996) with the addition of an amino-
terminal six-residue His tag (Brych et al., 2001) was used in this study.The QuikChange site-directed mutagenesis protocol (Stratagene)
was used to introduce the mutations (Glu81 to Ala, Val, Leu, Ser and
Thr) using mutagenic oligonucleotides of 25 to 31 bases in length
(Biomolecular Analysis Synthesis and Sequencing Laboratory,
Florida State University). All haFGF mutants were expressed using
the pET21a(+) plasmid/BL21(DE3) E. coli host expression system
(Invitrogen). Expression and puriﬁcation of haFGF were performed
following previously described procedures (Blaber et al., 1999;
Culajay et al., 2000; Brych et al., 2001).
2.2. Crystallization
The puriﬁed wild-type and mutant haFGFs were dialyzed against
50 mM sodium phosphate buffer (pH 7.5) containing 100 mM NaCl,
10 mM ammonium sulfate, 2 mM DTTand 0.5 mM EDTA, and then
concentrated to 38 to 40 mg ml
 1. Crystallization was performed by
hanging-drop vapor diffusion using formic acid as a precipitant. 2 ml
drops consisting of 1 ml of protein solution and 1 ml of mother liquor
were equilibrated against 1 ml of reservoir solution at 293 K for one
week. To ﬁnd suitable crystallization conditions, the crystallization
phase diagrams for the wild-type and all mutant haFGFs were drawn
from the result of crystallization using various concentrations of
haFGF (6, 10, 14, 18, 22, 26, 30 and 34 mg ml
 1) and formic acid (1.4,
1.8, 2.2, 2.6, 3.0, 3.4, 3.8, 4.2, 4.6, 5.0, 5.4 and 5.8 M).
2.3. Data collection and refinement
Diffraction data of the haFGF mutants were collected at BL41XU
(SPring-8), Hyogo, Japan. The crystals were mounted using a nylon
cryo loop (Hampton Research), frozen in a stream of liquid nitrogen
and cooled to 100 K during data collection. The intensity data were
processed using DENZO and merged with SCALEPACK (Otwi-
nowski & Minor, 1997). The crystals of Ser mutant belong to the same
space group (C2221) as the wild-type haFGF, with unit-cell para-
meters a = 73.5, b = 97.3, c = 108.5 A ˚ (Table 1). The structures of the
haFGF mutants were solved using the coordinates (PDB code: 1rg8)
of haFGF determined at 1.10 A ˚ resolution (Bernett et al., 2004) as an
initial model. Reﬁnement was carried out using the program
REFMAC5 in the CCP4 program suite (Collaborative Computa-
tional Project, Number 4, 1994). An atomic model was built using the
graphics program QUANTA (Accelrys Inc., San Diego, CA, USA).
3. Results and discussion
X-ray crystal analysis of the wild-type haFGF (Bernett et al., 2004)
showed that symmetry-related side chains of Glu81, located at a
crystal contact between haFGF molecules, were in close proximity.
This contact suggests that charge repulsion may disrupt suitable
crystal-packing interactions. To investigate whether the Glu residue
affects crystal formation, we constructed haFGF mutants in which
Glu81 was replaced by Ala, Val and Leu (potentially promoting
crystallization via hydrophobic effects) and Ser and Thr (potentially
promoting crystallization via reduction of side-chain entropy). All
mutant haFGF proteins were puriﬁed to apparent homogeneity for
crystallization trials.
From crystallization trials utilizing 96 different conditions, crystals
were grown in drops containing 4.2–4.6 M formate and 18–
34 mg ml
 1 of haFGF; however, E81V did not crystallize under any
conditions. If the slow crystal growth along the b axis is caused by the
charge repulsion at Glu81 or the surface conformational entropy, all
mutations (E81A, E81L, E81S and E81T) to remove these effects
should result in crystals with an improved thickness along the thin cell
edge. The crystals of the E81A and E81L mutants were, however,
grown as a thin plate similar to that of the wild type (Fig. 1a). The
E81S (26 mg ml
 1) and E81T (30 mg ml
 1) mutants were crystallized
to thicker-shaped crystals with dimensions of 0.4   0.4   0.3 mm for
4.2 M formate and 0.2   0.3   0.8 mm for 4.6 M formate, respectively
(Figs. 1b and 1c).
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Table 1
Data collection and reﬁnement statistics for E81S mutant haFGF.
Values in parentheses correspond to the highest-resolution shell (1.40–1.35).
Data collection
Space group C2221
Unit-cell dimensions (A ˚ ) a = 73.5, b = 97.3, c = 108.5
No. of molecules per asymmetric unit 2
Solvent content (%) 58
Resolutions (A ˚ ) 1.35
No. of observed reﬂections 530712
No. of unique reﬂections 81087
Redundancy 6.5 (5.7)
Completeness (%) 95.0 (82.3)
hI/ (I)i 49.0 (4.1)
Rmerge† 0.043 (0.349)
Wilson plot B factor (A ˚ 2) 15.7
Reﬁnement statistics
Resolutions (A ˚ ) 20.0–1.35
No. of reﬂections 76 990
R factor/Rfree‡ 0.182/0.211
R.m.s.d. bonds (A ˚ ) 0.015
R.m.s.d. angles ( ) 1.545
† Rmerge ¼ jIðhÞ h IðhÞij=IðhÞ, where hI(h)i is the average intensity of reﬂection h
and symmetry-related reﬂections. ‡ R ¼ Rfree ¼ jjFo   Fcjj=jFoj, calculated for the
reﬂections of the working and test (5%) sets.
Figure 1
The largest crystals of the wild-type and mutant haFGFs obtained during screening:
(a) haFGF, (b) E81S mutant and (c) E81T mutant.The crystal structure of the E81S mutant haFGF was determined to
1.35 A ˚ resolution in the same space group as the wild type by X-ray
crystallography. The reﬁned structure was compared with that of the
wild-type haFGF previously determined (Bernett et al., 2004). The
overall structure of E81S mutant haFGF was quite similar to that of
the wild type, including the noncrystallographic interaction between
monomers within an asymmetric unit. It was also found that one
formate molecule mediates a twofold crystal contact through four
hydrogen-bonding interactions involving side-chain hydroxy groups
of Ser81 (at a distance of 2.6 A ˚ ) and " amino groups of Lys101 (at a
distance of 3.5 A ˚ ) between crystallographically related molecules
(Fig. 2b). In this case, the formate molecule lies directly on the
twofold axis of symmetry (the C atom being centrosymmetric) and is
thought to be necessary to maintain the local electrostatic charge
neutrality, notably with the neighboring Lys101 side chains. There-
fore, the results suggest that the improvement of crystal growth along
the b axis may be caused not only by the removal of negative charge
repulsion of Glu81 but also by the formation of a hydrogen-bond
network in this crystal contact of haFGF.
In conclusion, the introduction of suitable molecular interactions
by protein engineering may allow improvement of the crystal growth.
Since the incorporation of hydrophobic residues to the interface of
haFGF rather prohibits the crystal growth, short hydrophilic residues
such as serine or threonine may be suitable for rebuilding the crystal
contact.
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Figure 2
The crystal contact region of the wild-type and E81S mutant haFGFs: (a) wild-type
haFGF and (b) E81S mutant.